Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 3/20 | 0.56 |
| ▸ | FNTB | P49356 | 3/20 | 0.56 |
| ▸ | PGGT1B | P53609 | 2/20 | 0.56 |
| ▸ | LTA4H | P09960 | 2/20 | 0.52 |
| ▸ | MMP2 | P08253 | 1/20 | 0.52 |
| ▸ | MMP7 | P09237 | 1/20 | 0.52 |
| ▸ | MMP9 | P14780 | 1/20 | 0.52 |
| ▸ | MMP12 | P39900 | 1/20 | 0.52 |
| ▸ | MMP13 | P45452 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Racemethionine SCHEMBL16758759 | 1.00 | FNTA (0.56) | FNTAFNTBPGGT1BLTA4HMMP2 | |
| SCHEMBL30051234 | 0.93 | FNTA (0.58) | FNTAFNTBPGGT1BLTA4H | |
| SCHEMBL907360 | 0.91 | FNTA (0.56) | FNTAFNTBPGGT1BLTA4H | |
| SCHEMBL30051374 | 0.91 | FNTA (0.61) | FNTAFNTBPGGT1BLTA4H | |
| SCHEMBL907359 | 0.91 | FNTA (0.56) | FNTAFNTBPGGT1BLTA4H | |
| SCHEMBL3646826 | 0.91 | FNTA (0.56) | FNTAFNTBPGGT1BLTA4H | |
| SCHEMBL10696437 | 0.90 | FNTA (0.60) | FNTAFNTBPGGT1BLTA4H | |
| SCHEMBL9442969 | 0.90 | FNTA (0.60) | FNTAFNTBPGGT1BLTA4H | |
| SCHEMBL9442973 | 0.90 | FNTA (0.60) | FNTAFNTBPGGT1BLTA4H | |
| SCHEMBL13154780 | 0.90 | FNTA (0.60) | FNTAFNTBPGGT1BLTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116507633-A | Glycosylated IL-2 proteins and uses thereof | 阿森迪斯药物肿瘤股份有限公司 | 2023-07-28 | — | — | CN | disclosed |
| CN-116133676-A | IL-2 sequences and uses thereof | 阿森迪斯药物肿瘤股份有限公司 | 2023-05-16 | — | — | CN | disclosed |
| WO-2015079692-A1 | UREA DERIVATIVE OR PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF | 杏林製薬株式会社 | 2015-06-04 | — | — | WO | disclosed |
| EP-2242743-A1 | AMINOPYRAZOLE DERIVATIVES | Actelion Pharmaceuticals Ltd. (CH) | 2010-10-27 | — | — | EP | disclosed |
| EP-2225231-A1 | AMINOTRIAZOLE DERIVATIVES AS ALX AGONISTS | Actelion Pharmaceuticals Ltd. (CH) | 2010-09-08 | — | — | EP | disclosed |
| WO-2009077990-A1 | AMINOTRIAZOLE DERIVATIVES AS ALX AGONISTS | ACTELION PHARMACEUTICALS LTD (CH) | 2009-06-25 | — | — | WO | disclosed |
| WO-2009077954-A1 | AMINOPYRAZOLE DERIVATIVES | ACTELION PHARMACEUTICALS LTD (CH) | 2009-06-25 | — | — | WO | disclosed |